Crossmark

First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass

Crossref DOI link: https://doi.org/10.1007/s00204-022-03294-2

Published Online: 2022-04-21

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vandeputte, Marthe M.

Verougstraete, Nick

Walther, Donna

Glatfelter, Grant C.

Malfliet, Jeroen

Baumann, Michael H.

Verstraete, Alain G.

Stove, Christophe P. https://orcid.org/0000-0001-7126-348X
Funding

Funding for this research was provided by:

Fonds Wetenschappelijk Onderzoek (1S81522N)

Fonds Wetenschappelijk Onderzoek (1703320N)

Fonds Wetenschappelijk Onderzoek (G069419N)

Bijzonder Onderzoeksfonds (01J15517)

National Institute on Drug Abuse
License Information

Text and Data Mining valid from 2022-04-21

Version of Record valid from 2022-04-21
More Information

Article History

Received: 7 February 2022

Accepted: 24 March 2022

First Online: 21 April 2022

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below